.svg){kind=logo}
Accurate, minute-to-minute glucose data combined with automated insulin delivery
Connected insulin pumps can prevent low and high glucose levels by automatically adjusting insulin delivery based on Libre 2 Plus, or Libre 3 Plus sensor readings.
NICE technology appraisal
for Hybrid Closed Loop systems
NICE now recommends Hybrid Closed Loop (HCL) systems for selected people with type 1 diabetes1
NICE guidelines for HCL
Benefits of HCL systems1,2
Improved HbA1c
Increased Time in Range
Reduced hypoglycaemia
.png){kind=icon}
Reduced diabetes distress
Improved quality of life
FreeStyle Libre systems* & partnerships
Omnipod® 5 Automated Insulin Delivery System
Authorised to work with the Libre 3 Plus and Libre 2 Plus sensors
Our 15-day sensors and the Omnipod 5 Automated Insulin Delivery system (AID) create one easy^, integrated experience for your patients.
Note that users should start their Libre 3 Plus or 2 Plus sensor with the Omnipod 5 System.
Pod shown without the necessary adhesive.
Tandem Automated Insulin Delivery System
Authorised to work with the Libre 3 Plus sensor
The Libre 3 Plus sensor and Tandem Diabetes Care AID system create one easy^, integrated experience.
Note that users should start their Libre 3 Plus sensor with the Tandem t:slim mobile app.
Not actual patient data. For illustrative purposes only.
Authorised to work with the Libre 3 Plus sensor
Minute-to-minute glucose readings combined with the myLoop automated insulin delivery system for easier diabetes management for your patients.3,^
Note that users should start their Libre 3 Plus sensor with the CamAPS FX app.
References & Disclaimers
Images are for illustrative purposes only. Not real patients, healthcare professionals, or data.
Omnipod is a registered trademark of Insulet Corporation and used with permission. Other trademarks are the property of their respective owners. The FreeStyle Libre 3 Plus and Libre 2 Plus sensors are authorised to work with the Omnipod 5 Automated Insulin Delivery System.
myLoop and YpsoPump are registered trademarks of mylife Diabetes Care AG or of its affiliates. CamAPS is a registered trademark of CamDiab Ltd.
Tandem Diabetes Care, Tandem logos, Control-IQ+, t:slim, t:slim X2, Tandem t:slim Mobile App and Tandem Source are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries.
* FreeStyle Libre system refers to the FreeStyle Libre 2 and FreeStyle Libre 3 systems.
1. NICE technology appraisal guidance TA943 (2023). Available at https://www.nice.org.uk/guidance/ta943. Accessed October 2026.
2. Crabtree TSJ, Griffin TP, Yap YW, Narendran P, Gallen G, Furlong N, Cranston I, Chakera A, Philbey C, Karamat MA, Saraf S, Kamaruddin S, Gurnell E, Chapman A, Hussain S, Elliott J, Leelarathna L, Ryder REJ, Hammond P, Lumb A, Choudhary P, Wilmot EG; ABCD Closed-Loop Audit Contributors. Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study. Diabetes Care. 2023 Oct 1;46(10):1831-1838. doi: 10.2337/dc23-0635. PMID: 37566697; PMCID: PMC10516256.
3. The FreeStyle Libre 3 Plus sensor is authorised for use with the myLoop automated insulin delivery (AID) system, including the CamAPS® FX app and YpsoPump insulin pump. For use of the FreeStyle Libre 3 Plus sensor with the myLoop, refer to the labeling provided with the CamAPS® FX app.
^ Based on product features including up to 15-day wear period, automatic readings every minute, accuracy data, and single-app setup with AID systems.
ADC-2646133 v7.0
